Sellas Life Sciences Group Inc (SLS)
R&D Expenses
$6.27M
Quarterly · Period ending: · USD
SLS R&D Expenses
Latest reported$6.27Mperiod ending
Latest reported$6.27Mperiod ending
SLS Quarterly R&D Expenses (-$48.00K → $6.27M)
Quarterly R&D Expenses
High-resolution chart · PNG
SLS r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 6,272,000 | |
| 5,129,000 | |
| 4,730,000 | |
| 4,216,000 | |
| 3,871,000 | |
| 3,205,000 | |
| 4,437,000 | |
| 4,362,000 | |
| 5,186,000 | |
| 5,111,000 | |
| 5,097,000 | |
| 5,813,000 | |
| 5,923,000 | |
| 7,174,000 | |
| 5,846,000 | |
| 4,282,000 | |
| 5,529,000 | |
| 4,611,000 | |
| 3,393,000 | |
| 4,541,000 | |
| 3,456,000 | |
| 4,284,000 | |
| 2,771,000 | |
| 2,367,000 | |
| 2,280,000 | |
| 1,864,000 | |
| 5,079,000 | |
| 1,799,000 | |
| 1,381,000 | |
| 1,859,000 | |
| 13,201,000 | |
| 1,720,000 | |
| 1,592,000 | |
| 1,804,000 | |
| 710,000 | |
| 951,000 | |
| 2,044,000 | |
| 2,362,000 | |
| 4,618,000 | |
| 3,624,000 | |
| 6,175,000 | |
| 5,443,000 | |
| 4,671,000 | |
| 5,740,000 | |
| 7,197,000 | |
| 5,825,000 | |
| 6,272,000 | |
| 7,025,000 | |
| 8,069,000 | |
| 6,770,000 | |
| 7,086,000 | |
| 3,633,000 | |
| 5,276,000 | |
| 5,081,000 | |
| 4,061,000 | |
| 4,169,000 | |
| 3,720,000 | |
| 3,392,000 | |
| 3,703,000 | |
| 1,367,000 | |
| 2,673,000 | |
| 2,156,000 | |
| 1,747,000 | |
| 1,936,000 | |
| 1,484,000 | |
| 1,926,000 | |
| 2,359,000 | |
| 2,091,000 | |
| 1,817,000 | |
| 1,416,000 | |
| 2,197,000 | |
| 1,116,000 | |
| 2,766,000 | |
| 1,088,000 | |
| 3,678,000 | |
| 1,023,000 | |
| 3,770,000 | |
| 824,000 | |
| -48,000 |